Information Provided By:
Fly News Breaks for March 2, 2018
OPK
Mar 2, 2018 | 06:31 EDT
JPMorgan analyst Eric Joseph downgraded Opko Health to Underweight without a price target. The analyst believes the company's Q4 miss raises "significant doubts" for the core diagnostics/ BRL business. He believes the stock will continue to see pressure going forward.
News For OPK From the Last 2 Days
There are no results for your query OPK